Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer

The Immune Microenvironment: A Major Player in Human Cancers

(2017) W.H. Fridman et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

(2014) A. Makkouk et al.   CANCER RESEARCH

Intratumoral Immunization: A New Paradigm for Cancer Therapy

(2014) A. Marabelle et al.   CLINICAL CANCER RESEARCH

New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy

(2014) K. S. Tewari et al.   CLINICAL CANCER RESEARCH

Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFN 

(2014) R.-S. Soong et al.   CLINICAL CANCER RESEARCH

CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer

(2014) Carlos Eduardo Coral de Oliveira et al.   DISEASE MARKERS

Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination

(2014) Yared Hailemichael et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis

(2014) Don-Kyu Kim et al.   NATURE MEDICINE

Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions

(2014) L. Maldonado et al.   Science Translational Medicine

CXCR3, a double-edged sword in tumor progression and angiogenesis

(2013) Clotilde Billottet et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer

(2013) Matthew P Morrow et al.   Expert Review of Vaccines

Immune responses against virus and tumor in cervical carcinogenesis: Treatment strategies for avoiding the HPV-induced immune escape

(2013) Pablo Conesa-Zamora   GYNECOLOGIC ONCOLOGY

Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy

(2013) Christel Devaud et al.   MOLECULAR THERAPY

Nivolumab plus Ipilimumab in Advanced Melanoma

(2013) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaginal Immunization to Elicit Primary T-Cell Activation and Dissemination

(2013) Elena Pettini et al.   PLoS One

Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer

(2013) Ramon Arens et al.   SEMINARS IN IMMUNOLOGY

Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model

(2013) Chung Truong Nguyen et al.   VACCINE

Immunotherapy in new pre-clinical models of HPV-associated oral cancers

(2013) Francesca Paolini et al.   Human Vaccines & Immunotherapeutics

B cell and T cell immunity in the female genital tract: Potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells

(2012) F. Anjuère et al.   CLINICAL MICROBIOLOGY AND INFECTION

Unique features of antiviral immune system of the vaginal mucosa

(2012) Yosuke Kumamoto et al.   CURRENT OPINION IN IMMUNOLOGY

Type I Interferons Maintain Foxp3 Expression and T-Regulatory Cell Functions Under Inflammatory Conditions in Mice

(2012) Shee Eun Lee et al.   GASTROENTEROLOGY

Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, α-/β-defensins and TLRs

(2012) Danica K Hickey et al.   Innate Immunity

Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses

(2012) Nicolas Çuburu et al.   JOURNAL OF CLINICAL INVESTIGATION

Treatment of Established Lesions Caused by High-risk Human Papilloma Virus Using a Synthetic Vaccine

(2012) Cornelis J. M. Melief   JOURNAL OF IMMUNOTHERAPY

Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice

(2012) S Domingos-Pereira et al.   Mucosal Immunology

Tertiary lymphoid organs in infection and autoimmunity

(2012) Katrijn Neyt et al.   TRENDS IN IMMUNOLOGY

The Present and Future of Peptide Vaccines for Cancer

(2011) Craig L. Slingluff   CANCER JOURNAL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

CXCR3 in T cell function

(2011) Joanna R. Groom et al.   EXPERIMENTAL CELL RESEARCH

Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions

(2011) Jeffrey C Nolz et al.   Immunotherapy

The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus

(2011) Yue Zhao et al.   NATURE

Innate immunity and adjuvants

(2011) S. Akira   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice

(2011) Chung Truong Nguyen et al.   VACCINE

Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection

(2011) Seol Hee Hong et al.   VACCINE

A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers

(2010) Loane Decrausaz et al.   INTERNATIONAL JOURNAL OF CANCER

Prophylactic and therapeutic implications of toll-like receptor ligands

(2010) Mona Hedayat et al.   MEDICINAL RESEARCH REVIEWS

Topical immunization strategies

(2010) C Czerkinsky et al.   Mucosal Immunology

Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice

(2009) Judith Del Campo et al.   VACCINE

Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals

(2008) Jung-Joon Min et al.   Nature Protocols